Comparison

Oritavancin diphosphate European Partner

Item no. M6133-50mg
Manufacturer AbMole
CASRN 192564-14-0
Amount 50mg
Category
Type Inhibitors
Specific against other
Purity >98%
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Alias LY 333328 diphosphate
Available
Target Information
Antibiotic
Molecular Weight
1989, 09
Solubility
10 mM in DMSO
Bioactivity information
Oritavancin is approved for the treatment of adult patients with acute bacterial skin and skin structure infections (SSSIs) caused by or suspected to be caused by susceptible isolates of designated gram-positive microorganisms.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 50mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close